Hosted on MSN2d
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
Fungi Lurking in Your Nose Could Be Worsening Your Allergies
A new study reveals that individuals with allergic rhinitis and asthma have distinct nasal fungal profiles, hinting at ...
Allergy Diagnostic Market Size to Hit Around USD13,193 Million by 2034
According to Statifacts, the global allergy diagnostic market size is calculated at USD 6,711 million in 2025 and is expected ...
LEADERSHIP Newspaper4d
The Truth About Allergies: Are They Really That Serious?
I have an allergic reaction when I eat melon soup” sounded like a joke till Majorie Konye was rushed to an emergency ward of a general hospital. We often ...
emjreviews.com6d
NICE Endorses First-of-Its-Kind Allergic Rhinitis Treatment
Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...